Caution to newcomers13 Mar 2018 07:51
1. We are talking humanised mice ... google humanised mice and their are numerous companies specialising in humanised mice.
2. The humanised mice are not the product the company floated on .. it has nothing to do with eliminating chemo for marrow transplants.
3. The collaboration is NOT new as if you read the RNS it tells you they were working together before.
4. It brings us no closer to the prize .. and is for a short period of four months.
5. We have 356 million shares . 356 000 000 ... and deal worth potential 256 thousand pounds ... or in pennies ... 25600000.
7. Take 25000000 pennies ( �256000) and dive by number of shares .. this deal worth �0.007 per share..
8. Prior to the unfortunate accidental I did not mean it I�m so sorry but hey take my money and run a marketing campaign tweet ... the company was trading in the �2� range.
9. Market dropped back almost to same range after reality that year/s to human trials on main product. This only floated last year as a bio stock .. and bio stocks float as they need MONEY to develop.
10. Provisional patent filed for one aspect of an existing product ... humanised mice ..
Company had �3 million at float .... has been spending money rent, materials, salary patent costs, marketing costs post tweet .. so now it has an extra �250,000.
Nothing to get excited about here